Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fallopian Tube Mucinous Adenocarcinoma × Contrast Media × Gynecologic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1 Fallopian Tube Mucinous Adenocarcinoma 1

Interventions

olaparib 1 liposomal doxorubicin 1 durvalumab 1 cediranib 1 Topotecan 1 Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Doxorubicin 1 Disulfides 1 Contrast Media 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04739800 2026-04-13

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

National Cancer Institute (NCI)

Phase 2 Active not recruiting

120 enrolled 19 charts

GenitourinaryGynecologic

Fallopian Tube Mucinous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡